BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 31465786)

  • 1. Transcriptomic analyses of gene expression by CRISPR knockout of miR-214 in cervical cancer cells.
    Sen P; Ghosal S; Hazra R; Arega S; Mohanty R; Kulkarni KK; Budhwar R; Ganguly N
    Genomics; 2020 Mar; 112(2):1490-1499. PubMed ID: 31465786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential transcriptome analysis in HPV-positive and HPV-negative cervical cancer cells through CRISPR knockout of miR-214.
    Sen P; Ganguly P; Kulkarni KK; Budhwar R; Ganguly N
    J Biosci; 2020; 45():. PubMed ID: 32975231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the microRNA profile in early-stage cervical squamous cell carcinoma by next-generation sequencing.
    Lin W; Feng M; Chen G; Zhou Z; Li J; Ye Y
    Oncol Rep; 2017 Mar; 37(3):1477-1486. PubMed ID: 28098890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Significantly Deregulated MicroRNAs in Recurrent Cervical Cancer Based on Bioinformatic Analysis of the Cancer Genome Atlas Data.
    Liu H; Liu L; Zhu H
    J Comput Biol; 2019 Apr; 26(4):387-395. PubMed ID: 30762435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-125a-5p modulates human cervical carcinoma proliferation and migration by targeting ABL2.
    Qin X; Wan Y; Wang S; Xue M
    Drug Des Devel Ther; 2016; 10():71-9. PubMed ID: 26766902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis of microRNA expression profiling studies in human cervical cancer.
    Li MY; Hu XX
    Med Oncol; 2015 Jun; 32(6):510. PubMed ID: 25920605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-138 is a potential biomarker and tumor suppressor in human cervical carcinoma by reversely correlated with TCF3 gene.
    Li H; Sheng Y; Zhang Y; Gao N; Deng X; Sheng X
    Gynecol Oncol; 2017 Jun; 145(3):569-576. PubMed ID: 28385388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long Noncoding RNA TP73-AS1 Targets MicroRNA-329-3p to Regulate Expression of the SMAD2 Gene in Human Cervical Cancer Tissue and Cell Lines.
    Guan MM; Rao QX; Huang ML; Wang LJ; Lin SD; Chen Q; Liu CH
    Med Sci Monit; 2019 Oct; 25():8131-8141. PubMed ID: 31663517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. microRNA-145 modulates epithelial-mesenchymal transition and suppresses proliferation, migration and invasion by targeting SIP1 in human cervical cancer cells.
    Sathyanarayanan A; Chandrasekaran KS; Karunagaran D
    Cell Oncol (Dordr); 2017 Apr; 40(2):119-131. PubMed ID: 27933466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. microRNA-944 overexpression is a biomarker for poor prognosis of advanced cervical cancer.
    Park S; Kim J; Eom K; Oh S; Kim S; Kim G; Ahn S; Park KH; Chung D; Lee H
    BMC Cancer; 2019 May; 19(1):419. PubMed ID: 31060525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-497 is a potential prognostic marker in human cervical cancer and functions as a tumor suppressor by targeting the insulin-like growth factor 1 receptor.
    Luo M; Shen D; Zhou X; Chen X; Wang W
    Surgery; 2013 Jun; 153(6):836-47. PubMed ID: 23453369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrative miRNA analysis identifies hsa-miR-3154, hsa-miR-7-3, and hsa-miR-600 as potential prognostic biomarker for cervical cancer.
    Zeng Y; Wang KX; Xu H; Hong Y
    J Cell Biochem; 2018 Feb; 119(2):1558-1566. PubMed ID: 28771797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant expression of miR-20a and miR-203 in cervical cancer.
    Zhao S; Yao DS; Chen JY; Ding N
    Asian Pac J Cancer Prev; 2013; 14(4):2289-93. PubMed ID: 23725129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.
    Luo M; Shen D; Wang W; Xian J
    Int J Clin Exp Pathol; 2015; 8(5):5542-8. PubMed ID: 26191262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-216b inhibits cell proliferation by targeting FOXM1 in cervical cancer cells and is associated with better prognosis.
    He S; Liao B; Deng Y; Su C; Tuo J; Liu J; Yao S; Xu L
    BMC Cancer; 2017 Oct; 17(1):673. PubMed ID: 28978307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive RNA-sequencing transcriptome profiling.
    Ahir BK; Lakka SS
    Cell Signal; 2019 Jan; 53():22-38. PubMed ID: 30244172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance and functions of microRNA-93/CDKN1A axis in human cervical cancer.
    Zhang X; Li F; Zhu L
    Life Sci; 2018 Sep; 209():242-248. PubMed ID: 30098344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPV16
    Pulati N; Zhang Z; Gulimilamu A; Qi X; Yang J
    J Gene Med; 2019 Nov; 21(11):e3126. PubMed ID: 31498525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA SOX21-AS1 promotes cervical cancer progression by competitively sponging miR-7/VDAC1.
    Zhang X; Zhao X; Li Y; Zhou Y; Zhang Z
    J Cell Physiol; 2019 Aug; 234(10):17494-17504. PubMed ID: 30912129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of miR-409-3p in regulation of HPV16/18-E6 mRNA in human cervical high-grade squamous intraepithelial lesions.
    Sommerova L; Anton M; Bouchalova P; Jasickova H; Rak V; Jandakova E; Selingerova I; Bartosik M; Vojtesek B; Hrstka R
    Antiviral Res; 2019 Mar; 163():185-192. PubMed ID: 30711417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.